Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum : Progress to Date and Next Steps
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Journal of clinical pharmacology - 59(2019), 6 vom: 17. Juni, Seite 779-783 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Eke, Ahizechukwu C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-HIV Agents |
|---|
| Anmerkungen: |
Date Completed 25.08.2020 Date Revised 16.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/jcph.1397 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM294461779 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM294461779 | ||
| 003 | DE-627 | ||
| 005 | 20231225081529.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jcph.1397 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0981.xml |
| 035 | |a (DE-627)NLM294461779 | ||
| 035 | |a (NLM)30821843 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Eke, Ahizechukwu C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum |b Progress to Date and Next Steps |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.08.2020 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a cobicistat | |
| 650 | 4 | |a pharmacoenhancers | |
| 650 | 4 | |a postpartum | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a ritonavir | |
| 650 | 7 | |a Anti-HIV Agents |2 NLM | |
| 650 | 7 | |a Cobicistat |2 NLM | |
| 650 | 7 | |a LW2E03M5PG |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Mirochnick, Mark H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical pharmacology |d 1973 |g 59(2019), 6 vom: 17. Juni, Seite 779-783 |w (DE-627)NLM000005576 |x 1552-4604 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2019 |g number:6 |g day:17 |g month:06 |g pages:779-783 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jcph.1397 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2019 |e 6 |b 17 |c 06 |h 779-783 | ||